Please use this identifier to cite or link to this item:
Title: The senseless orphanage of Chagas disease
Author: Alonso Vega, Cristina
Losada, Irene
Pinazo, María Jesús
Sancho Mas, Javier
Gascón i Brustenga, Joaquim
Alonso Padilla, Julio
Keywords: Malaltia de Chagas
Chagas' disease
Issue Date: 9-Dec-2019
Publisher: Taylor & Francis, Ltd.
Abstract: Introduction: Chagas disease is caused by the parasite Trypanosoma cruzi. Endemic in 21 American countries, there are ~7 million people infected, of which 14,000 die every year. Despite this burden, Chagas remains an orphan disease as it mainly affects poor communities with low economic and political power. Areas covered: There are two drugs available to treat the infection, but both have safety and efficacy issues. Investment in new treatments and other control measures has been historically neglected. This trend is changing and there are novel perspectives to put an end to this senseless orphanage. Research and development agenda of new therapies, diagnostic tools and biomarkers have moved forward during the last decade; and patients associations have been active in promoting awareness of the disease all along. Besides, the WHO recently declared April 14th as the ‘World Chagas disease day’, which will increase the visibility of the disease and attract attention internationally. Expert opinion: Efforts must focus on the prevention of new infections, but also in the management of the millions already chronically infected. This will require an integral approach where increasing the number of trained health workers and generalizing access to diagnosis and treatment will be fundamental.
Note: Versió postprint del document publicat a:
It is part of: Expert Opinion on Orphan Drugs, 2019, vol. 7, num. 12, p. 535-545
Related resource:
ISSN: 2167-8707
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Alonso-VegaC_Exp_Opin_Orphan_Drugs_2020_Postprint.pdf535.45 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.